Apotex Corp. Launches Generic Fertility Treatment Injectable Cetrorelix® in the United States
WESTON, Fla., May 14, 2024 /CNW/ - Apotex Corp. announced today the launch of Cetrorelix Acetate for Injection 0.25mg, a generic version of Cetrotide® in the United States.
Cetrorelix Acetate for Injection is a synthetic decapeptide with gonadotrophin-releasing hormone (GnRH) antagonist, indicated for the inhibition of premature LH surges in women undergoing controlled ovarian stimulation.
"This launch provides American women access to affordable fertility treatments," said Christine Baeder, President, Apotex Corp. "It demonstrates our unwavering focus on meeting patient needs with high-quality medication that is more accessible to everyone."
Please refer to the complete Prescribing information here for information on Warnings and Precautions, Adverse Reactions and Contraindications.
About Apotex Corp.
Apotex Corp. is a US-based company that sells high-quality, affordable and complex medicines to patients in the United States. Headquartered in Weston, Florida, Apotex Corp. and its global affiliates are committed to supplying patients with an integrated portfolio of generic, biosimilar and innovative branded pharmaceutical products.
Since its inception in 2022, SOLiTHOR has made huge advancements in its battery technology development. SOLiTHOR's all-solid-state lithium metal Gen1 prototype pouch cell has reached a milestone of 500 cycles, at full charge-discharge, with less than...
Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that it intends to offer and sell $500 million of shares of its common stock in an underwritten...
Two-time national champion Clemson University Head Football Coach Dabo Swinney, whose team will kick off the 2024 college football season against the Georgia Bulldogs in this year's Aflac Kickoff Game, surprised children at Prisma Health Children's...
Today, the U.S. Food and Drug Administration approved Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab) to treat certain rare diseases. Bkemv is approved for the following treatment indications, which are also...
Inland Empire Health Plan's (IEHP) Riverside Community Wellness Center (CWC) celebrated its first cohort of the 24/7 Dads program with a graduation ceremony for 22 participants on April 26....
